Listed

Vicarious Surgical Inc.

RBOTOTCCIK 1812173HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$9.3m, Q4 FY2025
Net income−$10.5m, Q4 FY2025
Vicarious Surgical Inc., income statement, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31
Research and development$m13.4Research and development, Q1 FY2023, three months to 2023-03-31$13.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure12.7Research and development, Q2 FY2023, three months to 2023-06-30$12.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figure13.0Research and development, Q3 FY2023, three months to 2023-09-30$13.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001213900-24-096886.Report this figure8.5Research and development, Q4 FY2023, three months to 2023-12-31$8.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-17, accession 0001213900-25-024588. Derived: 12-month figure less the 9-month figure.Report this figure10.0Research and development, Q1 FY2024, three months to 2024-03-31$10.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure10.9Research and development, Q2 FY2024, three months to 2024-06-30$10.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure10.8Research and development, Q3 FY2024, three months to 2024-09-30$10.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure8.5Research and development, Q4 FY2024, three months to 2024-12-31$8.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001213900-26-025189. Derived: 12-month figure less the 9-month figure.Report this figure9.4Research and development, Q1 FY2025, three months to 2025-03-31$9.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure9.1Research and development, Q2 FY2025, three months to 2025-06-30$9.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure8.0Research and development, Q3 FY2025, three months to 2025-09-30$8.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure7.1Research and development, Q4 FY2025, three months to 2025-12-31$7.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001213900-26-025189. Derived: 12-month figure less the 9-month figure.Report this figure
Operating income$m(22.3)Operating income, Q1 FY2023, three months to 2023-03-31−$22.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure(21.5)Operating income, Q2 FY2023, three months to 2023-06-30−$21.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figure(21.4)Operating income, Q3 FY2023, three months to 2023-09-30−$21.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001213900-24-096886.Report this figure(15.5)Operating income, Q4 FY2023, three months to 2023-12-31−$15.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-17, accession 0001213900-25-024588. Derived: 12-month figure less the 9-month figure.Report this figure(16.1)Operating income, Q1 FY2024, three months to 2024-03-31−$16.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure(17.7)Operating income, Q2 FY2024, three months to 2024-06-30−$17.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure(17.8)Operating income, Q3 FY2024, three months to 2024-09-30−$17.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure(15.0)Operating income, Q4 FY2024, three months to 2024-12-31−$15.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001213900-26-025189. Derived: 12-month figure less the 9-month figure.Report this figure(15.7)Operating income, Q1 FY2025, three months to 2025-03-31−$15.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure(13.5)Operating income, Q2 FY2025, three months to 2025-06-30−$13.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure(11.5)Operating income, Q3 FY2025, three months to 2025-09-30−$11.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure(9.3)Operating income, Q4 FY2025, three months to 2025-12-31−$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001213900-26-025189. Derived: 12-month figure less the 9-month figure.Report this figure
Interest expense$m0.0Interest expense, Q1 FY2023, three months to 2023-03-31$1.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure0.0Interest expense, Q2 FY2023, three months to 2023-06-30$1.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figure0.0Interest expense, Q3 FY2023, three months to 2023-09-30$1.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-13, accession 0001213900-23-086210.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$22.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-04, accession 0001213900-24-019594. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(26.9)Net income, Q1 FY2023, three months to 2023-03-31−$26.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure(15.3)Net income, Q2 FY2023, three months to 2023-06-30−$15.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figure(15.7)Net income, Q3 FY2023, three months to 2023-09-30−$15.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001213900-24-096886.Report this figure(13.1)Net income, Q4 FY2023, three months to 2023-12-31−$13.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-17, accession 0001213900-25-024588. Derived: 12-month figure less the 9-month figure.Report this figure(17.0)Net income, Q1 FY2024, three months to 2024-03-31−$17.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure(15.2)Net income, Q2 FY2024, three months to 2024-06-30−$15.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure(17.1)Net income, Q3 FY2024, three months to 2024-09-30−$17.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure(13.9)Net income, Q4 FY2024, three months to 2024-12-31−$13.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001213900-26-025189. Derived: 12-month figure less the 9-month figure.Report this figure(15.4)Net income, Q1 FY2025, three months to 2025-03-31−$15.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure(13.2)Net income, Q2 FY2025, three months to 2025-06-30−$13.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure(11.1)Net income, Q3 FY2025, three months to 2025-09-30−$11.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure(10.5)Net income, Q4 FY2025, three months to 2025-12-31−$10.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001213900-26-025189. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share(0.21)Diluted EPS, Q1 FY2023, three months to 2023-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure(3.62)Diluted EPS, Q2 FY2023, three months to 2023-06-30−$3.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figure(0.10)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2023-11-13, accession 0001213900-23-086210.Report this figurenot reported(0.10)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure(2.59)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$2.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Basic EPS$ per share(0.21)Basic EPS, Q1 FY2023, three months to 2023-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure(3.62)Basic EPS, Q2 FY2023, three months to 2023-06-30−$3.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figure(0.10)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2023-11-13, accession 0001213900-23-086210.Report this figurenot reported(0.10)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure(2.59)Basic EPS, Q2 FY2024, three months to 2024-06-30−$2.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Balance sheet

Cash and equivalents$2.6m, FY2025
Long-term debt$2.0m, FY2023
Shareholders' equity$9.8m, FY2025
Vicarious Surgical Inc., balance sheet, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31
Cash and equivalents$m54.1Cash and equivalents, Q1 FY2023, at 2023-03-31$54.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-05-08, accession 0001213900-23-037375.Report this figure32.8Cash and equivalents, Q2 FY2023, at 2023-06-30$32.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-07-28, accession 0001213900-23-060398.Report this figure59.1Cash and equivalents, Q3 FY2023, at 2023-09-30$59.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001213900-23-086210.Report this figure52.8Cash and equivalents, FY2023, at 2023-12-31$52.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-17, accession 0001213900-25-024588.Report this figure38.2Cash and equivalents, Q1 FY2024, at 2024-03-31$38.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure20.3Cash and equivalents, Q2 FY2024, at 2024-06-30$20.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figure7.1Cash and equivalents, Q3 FY2024, at 2024-09-30$7.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001213900-24-096886.Report this figure9.7Cash and equivalents, FY2024, at 2024-12-31$9.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-09, accession 0001213900-26-025189.Report this figure2.6Cash and equivalents, Q1 FY2025, at 2025-03-31$2.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure3.9Cash and equivalents, Q2 FY2025, at 2025-06-30$3.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure3.2Cash and equivalents, Q3 FY2025, at 2025-09-30$3.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure2.6Cash and equivalents, FY2025, at 2025-12-31$2.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-09, accession 0001213900-26-025189.Report this figure
Current assets$m101Current assets, Q1 FY2023, at 2023-03-31$101.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-05-08, accession 0001213900-23-037375.Report this figure85.3Current assets, Q2 FY2023, at 2023-06-30$85.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-07-28, accession 0001213900-23-060398.Report this figure113Current assets, Q3 FY2023, at 2023-09-30$113.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001213900-23-086210.Report this figure101Current assets, FY2023, at 2023-12-31$101.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-17, accession 0001213900-25-024588.Report this figure87.1Current assets, Q1 FY2024, at 2024-03-31$87.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure75.9Current assets, Q2 FY2024, at 2024-06-30$75.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figure64.0Current assets, Q3 FY2024, at 2024-09-30$64.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001213900-24-096886.Report this figure51.7Current assets, FY2024, at 2024-12-31$51.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-09, accession 0001213900-26-025189.Report this figure39.7Current assets, Q1 FY2025, at 2025-03-31$39.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure26.1Current assets, Q2 FY2025, at 2025-06-30$26.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure15.1Current assets, Q3 FY2025, at 2025-09-30$15.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure11.6Current assets, FY2025, at 2025-12-31$11.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-09, accession 0001213900-26-025189.Report this figure
Total assets$m121Total assets, Q1 FY2023, at 2023-03-31$121.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-05-08, accession 0001213900-23-037375.Report this figure105Total assets, Q2 FY2023, at 2023-06-30$104.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-07-28, accession 0001213900-23-060398.Report this figure132Total assets, Q3 FY2023, at 2023-09-30$132.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001213900-23-086210.Report this figure120Total assets, FY2023, at 2023-12-31$119.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-17, accession 0001213900-25-024588.Report this figure105Total assets, Q1 FY2024, at 2024-03-31$105.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure93.3Total assets, Q2 FY2024, at 2024-06-30$93.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figure80.6Total assets, Q3 FY2024, at 2024-09-30$80.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001213900-24-096886.Report this figure67.7Total assets, FY2024, at 2024-12-31$67.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-09, accession 0001213900-26-025189.Report this figure55.1Total assets, Q1 FY2025, at 2025-03-31$55.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure40.9Total assets, Q2 FY2025, at 2025-06-30$40.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure29.3Total assets, Q3 FY2025, at 2025-09-30$29.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure19.6Total assets, FY2025, at 2025-12-31$19.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-09, accession 0001213900-26-025189.Report this figure
Current liabilities$m6.7Current liabilities, Q1 FY2023, at 2023-03-31$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-05-08, accession 0001213900-23-037375.Report this figure7.5Current liabilities, Q2 FY2023, at 2023-06-30$7.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-07-28, accession 0001213900-23-060398.Report this figure7.8Current liabilities, Q3 FY2023, at 2023-09-30$7.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001213900-23-086210.Report this figure7.3Current liabilities, FY2023, at 2023-12-31$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-17, accession 0001213900-25-024588.Report this figure5.1Current liabilities, Q1 FY2024, at 2024-03-31$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure7.2Current liabilities, Q2 FY2024, at 2024-06-30$7.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figure8.6Current liabilities, Q3 FY2024, at 2024-09-30$8.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001213900-24-096886.Report this figure7.7Current liabilities, FY2024, at 2024-12-31$7.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-09, accession 0001213900-26-025189.Report this figure7.9Current liabilities, Q1 FY2025, at 2025-03-31$7.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure5.1Current liabilities, Q2 FY2025, at 2025-06-30$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure3.2Current liabilities, Q3 FY2025, at 2025-09-30$3.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure3.9Current liabilities, FY2025, at 2025-12-31$3.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-09, accession 0001213900-26-025189.Report this figure
Total liabilities$m33.4Total liabilities, Q1 FY2023, at 2023-03-31$33.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-05-08, accession 0001213900-23-037375.Report this figure28.8Total liabilities, Q2 FY2023, at 2023-06-30$28.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-07-28, accession 0001213900-23-060398.Report this figure24.2Total liabilities, Q3 FY2023, at 2023-09-30$24.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001213900-23-086210.Report this figure21.9Total liabilities, FY2023, at 2023-12-31$21.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-17, accession 0001213900-25-024588.Report this figure21.3Total liabilities, Q1 FY2024, at 2024-03-31$21.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure21.5Total liabilities, Q2 FY2024, at 2024-06-30$21.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figure22.7Total liabilities, Q3 FY2024, at 2024-09-30$22.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001213900-24-096886.Report this figure21.0Total liabilities, FY2024, at 2024-12-31$21.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-09, accession 0001213900-26-025189.Report this figure21.0Total liabilities, Q1 FY2025, at 2025-03-31$21.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure17.8Total liabilities, Q2 FY2025, at 2025-06-30$17.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure15.3Total liabilities, Q3 FY2025, at 2025-09-30$15.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure9.7Total liabilities, FY2025, at 2025-12-31$9.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-09, accession 0001213900-26-025189.Report this figure
Long-term debt$mnot reportednot reportednot reported2.0Long-term debt, FY2023, at 2023-12-31$2.0m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2024-03-04, accession 0001213900-24-019594.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Short-term borrowings$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m87.7Shareholders' equity, Q1 FY2023, at 2023-03-31$87.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figure75.7Shareholders' equity, Q2 FY2023, at 2023-06-30$75.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001213900-24-096886.Report this figure108Shareholders' equity, Q3 FY2023, at 2023-09-30$107.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001213900-24-096886.Report this figure98.0Shareholders' equity, FY2023, at 2023-12-31$98.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-09, accession 0001213900-26-025189.Report this figure84.0Shareholders' equity, Q1 FY2024, at 2024-03-31$84.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure71.9Shareholders' equity, Q2 FY2024, at 2024-06-30$71.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure57.9Shareholders' equity, Q3 FY2024, at 2024-09-30$57.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure46.7Shareholders' equity, FY2024, at 2024-12-31$46.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-09, accession 0001213900-26-025189.Report this figure34.1Shareholders' equity, Q1 FY2025, at 2025-03-31$34.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure23.1Shareholders' equity, Q2 FY2025, at 2025-06-30$23.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure14.1Shareholders' equity, Q3 FY2025, at 2025-09-30$14.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure9.8Shareholders' equity, FY2025, at 2025-12-31$9.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-09, accession 0001213900-26-025189.Report this figure

Cash flow

Operating cash flow−$9.3m, Q4 FY2025
Capital expenditure$0, Q2 FY2025
Vicarious Surgical Inc., cash flow, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31
Operating cash flow$m(18.6)Operating cash flow, Q1 FY2023, three months to 2023-03-31−$18.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure(15.1)Operating cash flow, Q2 FY2023, three months to 2023-06-30−$15.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-08-13, accession 0001213900-24-067807. Derived: 6-month figure less the 3-month figure.Report this figure(17.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$17.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001213900-24-096886. Derived: 9-month figure less the 6-month figure.Report this figure(11.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$11.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-17, accession 0001213900-25-024588. Derived: 12-month figure less the 9-month figure.Report this figure(14.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$14.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure(11.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$11.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001213900-25-075049. Derived: 6-month figure less the 3-month figure.Report this figure(12.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$12.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001213900-25-109320. Derived: 9-month figure less the 6-month figure.Report this figure(11.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$11.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001213900-26-025189. Derived: 12-month figure less the 9-month figure.Report this figure(11.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$11.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure(13.5)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$13.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001213900-25-075049. Derived: 6-month figure less the 3-month figure.Report this figure(10.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$10.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001213900-25-109320. Derived: 9-month figure less the 6-month figure.Report this figure(9.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$9.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001213900-26-025189. Derived: 12-month figure less the 9-month figure.Report this figure
Capital expenditure$m0.3Capital expenditure, Q1 FY2023, three months to 2023-03-31$306.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure0.2Capital expenditure, Q2 FY2023, three months to 2023-06-30$208.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-08-13, accession 0001213900-24-067807. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$118.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2023-11-13, accession 0001213900-23-086210. Derived: 9-month figure less the 6-month figure.Report this figure1.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-17, accession 0001213900-25-024588. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001213900-25-075049. Derived: 6-month figure less the 3-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001213900-25-075049. Derived: 6-month figure less the 3-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)5.95m, Q3 FY2025
Vicarious Surgical Inc., shares, quarterly
Line itemUnitQ1 FY20222022-03-31Q2 FY20222022-06-30Q3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30
Diluted shares (weighted)m shares128Diluted shares (weighted), Q1 FY2022, three months to 2022-03-31127,593,181 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-08, accession 0001213900-23-037375.Report this figure121Diluted shares (weighted), Q2 FY2022, three months to 2022-06-30121,341,460 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-07-28, accession 0001213900-23-060398.Report this figure122Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30121,965,277 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001213900-23-086210.Report this figure126Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31126,130,189 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-29, accession 0001213900-24-037265.Report this figure4.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-304,233,072 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001213900-24-067807.Report this figure5.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-305,171,380 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001213900-24-096886.Report this figure5.9Diluted shares (weighted), Q1 FY2024, three months to 2024-03-315,856,983 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure5.9Diluted shares (weighted), Q2 FY2024, three months to 2024-06-305,873,019 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure5.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-305,899,616 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure5.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-315,924,397 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001213900-25-042087.Report this figure5.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-305,938,282 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001213900-25-075049.Report this figure6.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-305,954,405 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001213900-25-109320.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.